Identification of miRNA Biomarkers Associated With Staphylococcal Musculoskeletal Infections

Claudia Siverino1, Eric Sumrall1, Jorge Úbeda Garrido1

  • 1AO Research Institute Davos, Davos Platz, Switzerland.

Insights

This study identifies four microRNAs (miRNAs) as potential biomarkers for diagnosing Staphylococcus aureus musculoskeletal infections (MSKIs). These specific miRNAs can help differentiate S. aureus from S. epidermidis infections, aiding orthopedic surgery.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Musculoskeletal infections (MSKIs) present significant challenges in orthopedic surgery, often caused by Staphylococcus aureus and S. epidermidis.
  • Early diagnosis is critical for effective treatment and preventing chronic infection.
  • MicroRNAs (miRNAs) are emerging as potential diagnostic biomarkers for various conditions.

Purpose of the Study:

  • To evaluate serum miRNA expression in patients with staphylococcal MSKIs.
  • To identify specific miRNAs that can serve as diagnostic biomarkers for differentiating S. aureus from S. epidermidis infections.
  • To explore the role of these miRNAs in the immune response to bacterial infections.

Main Methods:

  • Serum samples were collected from patients with confirmed S. aureus MSKI, S. epidermidis MSKI, and healthy controls.
  • RNA sequencing was performed to analyze miRNA expression profiles.
  • Validation of differentially expressed miRNAs was conducted using quantitative real-time PCR.
  • Receiver operating characteristic (ROC) curve analysis was used to assess diagnostic accuracy.

Main Results:

  • Significant differences in miRNA expression were observed between S. aureus, S. epidermidis, and control groups.
  • Specific miRNAs (hsa-miR-1246, hsa-miR-483-5p, hsa-miR-1290, hsa-miR-1-3p, hsa-miR-148b-3p, hsa-miR-23a-3p) were identified as differentially expressed.
  • A panel of four miRNAs (miR-1246, miR-1290, miR-148b-3p, and miR-23a-3p) demonstrated high diagnostic accuracy (AUC=0.96) in distinguishing S. aureus from S. epidermidis infections.

Conclusions:

  • This study identified a panel of four miRNAs with potential as diagnostic biomarkers for S. aureus MSKIs.
  • These miRNAs can aid in differentiating between S. aureus and S. epidermidis infections, improving orthopedic surgical outcomes.
  • Further research into the immunomodulatory roles of these miRNAs in bacterial infections is warranted.